NCT01142856View on ClinicalTrials.gov

Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS)

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Amyotrophic Lateral Sclerosis
Interventions
BIOLOGICAL

autologous mesenchymal stem cells

single intrathecal dose of 10x6 cells by lumbar puncture.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER